↓ Skip to main content

Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus

Overview of attention for article published in Frontiers in immunology, June 2019
Altmetric Badge

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Readers on

mendeley
92 Mendeley